| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |